Home › Funds › Winthrop Partners - WNY, LLC › ABBV

Winthrop Partners - WNY, LLC position in ABBV

ABBVIE INC · Health Care

Winthrop Partners - WNY, LLC reported holding 5,151 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.77% of its reported portfolio and ranking #37 among its reported holdings. Winthrop Partners - WNY, LLC has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)5.15K sh
Reported value held$1.35M
Portfolio Weight0.77%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Winthrop Partners - WNY, LLC's ABBV position evolved

Winthrop Partners - WNY, LLC first disclosed a stake in ABBV in Q4 2025 at 5,766 shares (US$1.3M). The position peaked in Q2 2026 at 5,801 shares, worth US$1.5M. Across 4 filings, Winthrop Partners - WNY, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,151 shares valued at US$1.3M — a reduction of -650 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 5.77K $1.32M New
Q1 2026 5.72K $1.24M Reduce
Q2 2026 5.80K $1.46M Add
Q3 2026 5.15K $1.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Winthrop Partners - WNY, LLC held ABBV?

Winthrop Partners - WNY, LLC has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Winthrop Partners - WNY, LLC's current position in ABBV?

As of Q3 2026, Winthrop Partners - WNY, LLC holds 5.15K shares of ABBV (ABBVIE INC), valued at $1.35M, representing 0.77% of its reported portfolio and ranking #37.

Has Winthrop Partners - WNY, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Winthrop Partners - WNY, LLC reduced its position in ABBV. The position peaked in Q2 2026 at 5.80K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.